IL6 and posterior cortical atrophy: Exposure of PCa LNCaP cell line to Bicalutamide—an AR LBD antagonist—resulted in a 70% decrease in the IL-6 induced expression of AR target gene PSA, indicating the role of IL-6 signalling in promoting AR activity [43].